Last updated on May 2018

Ascorbic Acid Levels in MDS AML and CMML Patients


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: MYELODYSPLASTIC SYNDROME | Acute myeloid leukemia | Chronic myelomonocytic leukemia | miller-dieker syndrome | Preleukemia
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients actively receiving treatment for acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML).
  • Patients diagnosed with AML, MDS, or CMML and are treatment nave.
  • Patients who are 18 years old or older.

Exclusion Criteria:

  • Patients deemed as too ill to participate as determined by the clinical investigator.
  • Non-English speaking patients
  • Patients unable to provide informed consent.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.